Tim Holzer
Executive Director, Clinical Diagnostics Laboratory Eli Lilly
With 20 years of clinical laboratory experience developing blood- and tissue-based tests for novel clinical trial biomarkers, Tim streamlines adoption of emerging technologies into biomarker strategies, impacting both drug and diagnostic advancement.
Seminars
Thursday 23rd October 2025
Building Internal Spatial Biology Infrastructure: Lessons from Multi- Platform Implementation in Ulcerative Colitis Research
9:30 am
- Systematic multi-platform comparative studies of workflow requirements and output metrics to inform critical laboratory infrastructure decisions
- Implementation of pathologist-guided tissue quality reviews along with RNA quality assessments
- Application to studies of ulcerative colitis, assessments of intestinal fibrosis, and custom analytical tools to compare data across technologies
NEW DATA!
Thursday 23rd October 2025
Panel Discussion: Leveraging Spatial Biology to Unlock Novel Insights into Complex Disease for Enhanced Therapeutic & Biomarker Development
11:30 am
- What are some of the most promising ways spatial biology is helping us better understand complex disease mechanisms that traditional approaches may miss?
- How can we translate novel spatial insights into robust, clinically relevant biomarkers and therapeutic targets that hold up across different patient populations?
- What practical steps are needed to integrate spatial biology more effectively into discovery and development pipelines?
